Other substances

Xue Bi Jing

A Traditional Chinese Medicine formulation.

Phase of research

Potential treatment - clinical evidence

How it helps

Other treatment

Drug status

Natural product

2
 Supporting references
0
 Contradictory references
15
 AI-suggested references
0
 Clinical trials

General information

Xue Bi Jing Injection consists of numerous compounds, which are extracted from five medicinal plants: Carthamus tinctorius, Radix Paeoniae Rubra, Ligusticum wallichii, Salvia miltiorrhiza, and Angelica sinensis (Guo et al., 2020). 

Synonyms

Xuebijing

 

Supporting references

Link Tested on Impact factor Notes Publication date
Molecular mechanism of action of repurposed drugs and traditional Chinese medicine used for the treatment of patients infected with COVID-19: A systematic scoping review
Preprint 		Patients

injection for treatment of severe clinical symptoms

 May/04/2020
Xuebijing injection in the treatment of COVID-19: a retrospective case-control study
IL-6 TCM Mixed substance Cohort study 		Patients 1.37

Adjunctive Xue Bi Jing treatment could be beneficial; although, a significant difference between the observed and matched control groups was not observed. Sample size: 42 observational group prior to matching and 16 + 16 matched control afterwards. Dosage: 100 mL IV twice daily for at least 7 consecutive days.


 Sep/10/2020

AI-suggested references

Link Publication date
[Evaluation of clinical value of Xuebijing combined with human immunoglobulin in severe and critically ill patients with coronavirus disease 2019].
Jan/06/2021
Molecular mechanisms revealed by network pharmacology of Xuebijing on the treatment of acute respiratory distress syndrome caused by novel coronavirus infection.
Jun/05/2020
[Effect of Xuebijing injection on inflammatory markers and disease outcome of coronavirus disease 2019].
Dec/30/2021
[A multicenter prospective cohort study of Xuebijing injection in the treatment of severe coronavirus disease 2019].
Aug/21/2021
Pharmacological development of the potential adjuvant therapeutic agents against coronavirus disease 2019
Jun/23/2020
The preventive effect of Xuebijing injection against cytokine storm for severe patients with COVID-19: A prospective randomized controlled trial.
Jan/30/2021
Composition, Clinical Efficiency, and Mechanism of NHC-Approved "Three Chinese Medicines and Three Chinese Recipes" for COVID-19 Treatment
Feb/04/2022
Traditional Chinese medicine network pharmacology study on exploring the mechanism of Xuebijing Injection in the treatment of coronavirus disease 2019
Dec/29/2020
Natural products and phytochemicals as potential anti-SARS-CoV-2 drugs
Jun/16/2021
Network pharmacology and RNA-sequencing reveal the molecular mechanism of Xuebijing injection on COVID-19-induced cardiac dysfunction
Nov/22/2021
Examining the effector mechanisms of Xuebijing injection on COVID-19 based on network pharmacology.
Oct/16/2020
Identifying the molecular targets and mechanisms of xuebijing injection for the treatment of COVID-19 via network pharmacology and molecular docking
Mar/06/2021
Efficacy and safety assessment of severe COVID-19 patients with Chinese medicine: A retrospective case series study at early stage of the COVID-19 epidemic in Wuhan, China.
Jan/30/2021
Traditional Chinese Medicine (TCM) in the treatment of COVID-19 and other viral infections: Efficacies and mechanisms.
Mar/31/2021
Network Pharmacology Analysis to Identify Phytochemicals in Traditional Chinese Medicines That May Regulate ACE2 for the Treatment of COVID-19
Nov/05/2020
Export (.csv)